B-cell depletion in SLE: clinical and trial experience with rituximab and ... 7thSpace Interactive (press release) In recent years there have been many publications regarding the experience in SLE of B-cell depletion utilising rituximab, an anti-CD20 mAb that temporarily depletes B cells, reporting promising results in uncontrolled open studies and in routine ... |
